Company: OFIX
Filing Date: 2025-04-30
Form Type: DEF 14A
Source: 0000950170-25-061062
Chunk: 45

Company: Orthofix Medical Inc.
Filing Date: 2025-04-30
Form: DEF 14A
Chunk 45
---
 This information includes a specific review of dollar amounts for salary, target bonus opportunity, and long-term equity-based incentive compensation. The charts below show the annual total target direct compensation (full-year base salary, target annual cash incentive compensation, and long-term equity incentive compensation award values at target) for Mr. Calafiore, our President and Chief Executive Officer, and our other named executive officers for 2024. These charts illustrate that 92% of our President and Chief Executive Officer’s annual total target direct compensation and 83% of our other named executive officers’ annual total target direct compensation was performance-based or variable.

<div align='center'>36</div>

Annual Salary The Committee recommends, for approval by the Board, the annual salary for our President and Chief Executive Officer and determines the annual salary for our other Section 16 officers and members of our ELT. In making these recommendations and determinations, the Committee considers proxy peer data and/or market survey data for each individual person, with the midpoint of the salary range being the 50 th percentile of the market. The Committee positions actual base salary within the salary range based on a variety of factors including an executive’s experience, performance, and contribution to Orthofix’s success. The Committee endeavors to use the full width of the salary range to differentiate pay. The 2024 annual base salary amounts for our NEOs were as follows:

| Name                                     
 Active Officers as of December 31, 2024: | Title (1)                                          | 2024 Annual 
 Base Salary |         |
|:-----------------------------------------|:---------------------------------------------------|:------------|--------:|
| Massimo Calafiore                        | President and Chief Executive Officer and Director | $           | 825,000 |
| Julie Andrews                            | Chief Financial Officer                            | $           | 475,000 |
| J. Andrés Cedrón                         | Chief Legal Officer                                | $           | 470,000 |
| Geoffrey C. Gillespie(2)                 | Chief Accounting Officer and Former Interim        
 Chief Financial Officer                            | $           | 304,500 |
| Max Reinhardt                            | President, Global Spine                            | $           | 480,000 |
| Lucas Vitale                             | Chief People and Business Operations Officer       | $           | 460,000 |
| Former Officers:                         |                                                    |             |         |
| Catherine M. Burzik(3)                   | Former Interim Chief Executive Officer             | $           | 825,000 |
| Kimberley A.